1 July 2021 in International Journal of Women's Health
Purpose: In February 2020, Italy became the first European country to face the coronavirus disease 2019 (COVID-19) outbreak. The concerns of infection, financial worries, loss of freedom, and isolation during the ongoing pandemic can lead to negative psychological effects, including anxiety, depression, and obsessive-compulsive disorder. The main aim of our study was to evaluate the relationship between pandemic-related stress and pregnancy-specific stress and assess their role in the development of psychiatric symptoms. We predicted that pregnancy-specific stress would mediate an association of pandemic-related stress with psychiatric symptoms. Patients and Methods: A total of 258 pregnant women were assessed for general emotional symptoms with the General Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-2 (PHQ-2), and an Obsessive-Compulsive Disorder screening (OCD). The Revised Prenatal Distress Questionnaire (NuPDQ) and the Pandemic-Related Pregnancy Stress Scale (PREPS) were administered as measures of pregnancy-specific stress (PSS and pandemic-related, respectively). Mediation effects by NuPDQ for PREPS stress scales on psychiatric outcomes were calculated, using regression series and correcting for general covariates. Results: Almost a third of the sample reported clinically relevant anxiety levels (32.6%), 11.2% were positive for OCD screening and less than 5% were positive for depression screening. The stress related to feeling unprepared for delivery and postpartum (PREPS-PS) predicted PHQ-2 score, both directly and indirectly via PSS, and it predicted GAD-7 score only indirectly. The stress related to fear of infection (PREPS-PIS) was directly associated to GAD-7 score and – through PSS – to PHQ-2 score and OCD. Conclusion: The pandemic onset contributed to poor mental health, especially anxiety, in a substantial portion of Italian pregnant women. Our results emphasize the importance of strategies to reduce pregnancy-specific stress, as well as to diminish stress due to the pandemic. Identifying risk factors for psychological suffering is important to prevent potential long-term consequences for mothers and their offspring.
1 March 2021 in Health Policy and Technology
1 November 2021 in Journal of Affective Disorders
1 January 2022 in Journal of Affective Disorders
6 July 2024 in Physics of Life Reviews
26 June 2026 in The British Journal of Psychiatry
Background: Lithium is the gold-standard treatment for bipolar disorder, yet its use is often restricted by the logistical burden of regular venous blood sampling and laboratory monitoring. Point-of-care testing (POCT) offers a potential alternative, but evidence regarding acceptability and analytical performance is limited. Aims: To evaluate patient and clinician attitudes towards POCT for lithium monitoring and analytically validate a novel POCT device (Medimate Multireader) against a reference laboratory method. Method: We combined patient and clinician surveys on attitudes towards lithium treatment and monitoring with an analytical evaluation of the Medimate Multireader, a novel POCT device. Survey data explored perceived barriers to lithium use and preferences for monitoring methods. Analytical validation assessed accuracy, bias, agreement and reproducibility compared with a reference laboratory method. Results: Most patients and clinicians preferred POCT to conventional venous sampling. Many patients described venous monitoring as inconvenient and disruptive and indicated that they would be more willing to take lithium if home-based POCT were available. Clinicians identified the frequency and logistical demands of venous blood testing as the principal barrier to prescribing lithium. The Medimate Multireader demonstrated excellent analytical agreement with the reference method, with a correlation coefficient of 0.96 and mean bias and limits of agreement within the predefined ±0.2 mmol/L performance specification. The potential of the device for patient-operated home-based testing was viewed favourably by survey respondents. Conclusions: POCT for lithium provides a feasible and analytically robust alternative to venous blood monitoring. By reducing the logistical burden of regular venous sampling, a key barrier to lithium use, POCT aligns with National Health Service priorities for digitally enabled community-based care and may support improved access, safety and adherence.